Pressmeddelanden från Arctic Bioscience

Bevaka pressreleaser

Start Nyheter Pressreleaser Riktkurser Insynshandel Blankning Analyser Bloggar Videos Podcasts

I förrgår 12:49

Arctic Bioscience

Arctic Bioscience – New peer‑reviewed study shows herring roe phospholipids stimulate anti‑inflammatory pathways in cells 26 feb 07:00

Arctic Bioscience

Arctic Bioscience – Q4 2025 Operational update – Positive outlook for 2026 23 feb 13:09

Arctic Bioscience

Arctic Bioscience – Invitation to presentation of Q4 2025 operational update 29 jan 08:30

Arctic Bioscience

Arctic Bioscience invited to present at the Glaucoma 360 New Horizons Forum 17 dec 2025 11:37

Arctic Bioscience

Arctic Bioscience – Share capital increase registered 12 dec 2025 16:05

Arctic Bioscience

Arctic Bioscience – Board approval of share capital increase related to conversion of debt 09 dec 2025 08:29

Arctic Bioscience

Arctic Bioscience – Exercise of right to convert debt and issuance of shares 11 nov 2025 12:03

Arctic Bioscience

Arctic Bioscience – Minutes of the Extraordinary General Meeting 10 nov 2025 07:00

Arctic Bioscience

Arctic Bioscience – Q3 2025 Operational update – Significant results on systemic inflammation 07 nov 2025 08:00

Arctic Bioscience

Arctic Bioscience – Invitation to presentation of Q3 operational update and HeROPA-analyses results 04 nov 2025 08:51

Arctic Bioscience

Arctic Bioscience – Analysis on HeROPA study shows statistically significant effects of psoriasis drug candidate HRO350 on inflammation 28 okt 2025 09:30

Arctic Bioscience

Arctic Bioscience – Notice of Extraordinary General Meeting on 11 November 2025 28 aug 2025 08:00

Arctic Bioscience

Arctic Bioscience – Stable development with upside potential 21 aug 2025 12:19

Arctic Bioscience

Arctic Bioscience – Invitation to presentation of half year 2025 results 18 aug 2025 10:28

Arctic Bioscience

Arctic Bioscience - Achieves significant vision improvement in Clinical Glaucoma Study 12 aug 2025 13:46

Arctic Bioscience

Arctic Bioscience launches new skin care product – Romega Skin Refine 01 jul 2025 17:00

Arctic Bioscience

Arctic Bioscience – 12-month data confirm potential for HRO350 in mild-to-moderate psoriasis 26 maj 2025 11:59

Arctic Bioscience

Arctic Bioscience – Minutes of the Annual General Meeting 15 maj 2025 08:00

Arctic Bioscience

Arctic Bioscience – Q1 2025 Operational update – Growth-platform established 12 maj 2025 11:33

Arctic Bioscience

Arctic Bioscience – Share capital increase registered 12 maj 2025 09:00

Arctic Bioscience

Arctic Bioscience – Notice of Annual General Meeting on 26 May 2025 08 maj 2025 18:50

Arctic Bioscience

Arctic Bioscience – Board approval of share capital increase related to conversion of debt 07 maj 2025 07:30

Arctic Bioscience

Arctic Bioscience – Annual report 2024 28 apr 2025 08:37

Arctic Bioscience

Arctic Bioscience – Exercise of right to convert debt and issuance of shares 24 apr 2025 16:42

Arctic Bioscience

Arctic Bioscience announces encouraging top-line results from the HeROPA clinical study 01 apr 2025 08:32

Arctic Bioscience

Arctic Bioscience – HeROPA 1-year read-out: Top-line results expected within 2-3 weeks 27 feb 2025 08:00

Arctic Bioscience

Arctic Bioscience – Q4 2024 Operational update – Strong ending to 2024 20 feb 2025 10:00

Arctic Bioscience

Arctic Bioscience – Invitation to presentation of Q4 2024 operational update 10 feb 2025 07:53

Arctic Bioscience

Arctic Bioscience – Share capital increase registered 03 feb 2025 15:42

Arctic Bioscience

Arctic Bioscience – Board approval of share capital increase related to conversion of debt 30 jan 2025 08:52

Arctic Bioscience

Arctic Bioscience – Exercise of right to convert debt and issuance of shares 21 jan 2025 11:25

Arctic Bioscience

Arctic Bioscience – Joint Venture with Kotler to develop China and other SE Asian markets 13 jan 2025 17:45

Arctic Bioscience

Arctic Bioscience – Primary insiders participating in convertible loan facility 13 jan 2025 17:00

Arctic Bioscience

Arctic Bioscience – funded to cash positive 19 nov 2024 12:12

Arctic Bioscience

Arctic Bioscience – Minutes of the Extraordinary General Meeting 05 nov 2024 09:00

Arctic Bioscience

Arctic Bioscience – Notice of Extraordinary General Meeting on 19 November 2024 29 okt 2024 07:00

Arctic Bioscience

Arctic Bioscience – Q3 2024 Operational update 21 okt 2024 16:53

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 18 okt 2024 20:15

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 18 okt 2024 13:40

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 18 okt 2024 11:41

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 17 okt 2024 10:10

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 16 okt 2024 12:42

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 16 okt 2024 10:08

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 16 okt 2024 08:00

Arctic Bioscience

Arctic Bioscience – Presentation for today’s webcast 15 okt 2024 15:52

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 15 okt 2024 08:15

Arctic Bioscience

Arctic Bioscience – Invitation to webcast – HeROPA read-out 14 okt 2024 19:08

Arctic Bioscience

Arctic Bioscience - Announces top-line results from the phase 2b HeROPA study 25 sep 2024 08:00

Arctic Bioscience

Arctic Bioscience – New cellular research showing anti-psoriatic effects 20 sep 2024 13:47

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 29 aug 2024 08:00

Arctic Bioscience

Arctic Bioscience - Study de-risked by all needed patients passed 6 months, read-out expected in 4-6 weeks 22 aug 2024 10:02

Arctic Bioscience

Arctic Bioscience – Invitation to presentation of half year 2024 results 26 jul 2024 09:42

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 02 jul 2024 15:58

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 26 jun 2024 10:00

Arctic Bioscience

Arctic Bioscience – New positive data showing anti-inflammatory effects of phospholipid esters from herring roe in immune cells 29 apr 2024 08:00

Arctic Bioscience

Arctic Bioscience – Q1 2024 Operational update – Progress according to plan 26 apr 2024 12:02

Arctic Bioscience

Arctic Bioscience – Minutes of the Annual General Meeting 12 apr 2024 10:00

Arctic Bioscience

Arctic Bioscience – Notice of Annual General Meeting on 26 April 2024 09 apr 2024 08:00

Arctic Bioscience

Arctic Bioscience – Annual report 2023 15 mar 2024 10:22

Arctic Bioscience

Arctic Bioscience – Extension of share options to members of management group 01 mar 2024 08:00

Arctic Bioscience

Arctic Bioscience – Q4 2023 Operational update – Foundation for an exciting 2024 28 feb 2024 17:08

Arctic Bioscience

Arctic Bioscience – Treatment start for 519 patients in the HeROPA-study 22 feb 2024 09:24

Arctic Bioscience

Arctic Bioscience – Invitation to presentation of Q4 2023 operational update 17 jan 2024 08:45

Arctic Bioscience

Arctic Bioscience – Recruitment completed in the phase IIb HeROPA clinical trial 01 dec 2023 08:00

Arctic Bioscience

Arctic Bioscience – More than 75% recruited in the phase IIb HeROPA clinical trial 02 nov 2023 08:00

Arctic Bioscience

Arctic Bioscience – Q3 2023 Operational update – More than 50% recruited in the phase IIb HeROPA clinical trial 29 aug 2023 08:00

Arctic Bioscience

Arctic Bioscience – HeROPA study recruitment progressing well and strong nutra revenue growth 22 aug 2023 09:22

Arctic Bioscience

Arctic Bioscience – Invitation to presentation of half year 2023 results 07 jul 2023 11:56

Arctic Bioscience

Arctic Bioscience – Credit facility of NOK 30 mill. established 08 maj 2023 08:20

Arctic Bioscience

Arctic Bioscience – Share capital increase registered 08 maj 2023 08:00

Arctic Bioscience

Arctic Bioscience – Q1 2023 Operational update – HeROPA clinical trial approved in all 5 countries and ongoing 24 apr 2023 09:25

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 21 apr 2023 15:10

Arctic Bioscience

Arctic Bioscience – Approval of share capital increase 21 apr 2023 14:49

Arctic Bioscience

Arctic Bioscience – Minutes of the Annual General Meeting 14 apr 2023 10:00

Arctic Bioscience

Arctic Bioscience – Notice of Annual General Meeting on 21 April 2023 29 mar 2023 08:00

Arctic Bioscience

Arctic Bioscience – Annual report 2022 23 mar 2023 09:20

Arctic Bioscience

Arctic Bioscience – Invitation to presentation of full year 2022 results 17 mar 2023 08:16

Arctic Bioscience

Arctic Bioscience – Share capital increase registered 14 mar 2023 10:29

Arctic Bioscience

Arctic Bioscience – Extension of share options to members of management group 07 mar 2023 10:36

Arctic Bioscience

Arctic Bioscience – The HeROPA phase IIb clinical trial approved in Norway, Finland, Germany and Poland 07 mar 2023 09:23

Arctic Bioscience

Arctic Bioscience – Board approval of share capital increase related to share option exercise 27 feb 2023 17:05

Arctic Bioscience

Arctic Bioscience – Exercise of share options and issuance of shares 23 feb 2023 14:27

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 22 feb 2023 12:13

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 16 feb 2023 14:27

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 14 feb 2023 11:51

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 13 feb 2023 18:36

Arctic Bioscience

Arctic Bioscience – Account for agreement 13 feb 2023 16:32

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 13 feb 2023 15:03

Arctic Bioscience

Arctic Bioscience – Mandatory notification of trade 13 feb 2023 12:52

Arctic Bioscience

Arctic Bioscience – Entering micro algae space 09 feb 2023 07:30

Arctic Bioscience

Arctic Bioscience – Q4 2022 Operational update – Key pharma milestones achieved and significant growth in revenues 01 feb 2023 07:30

Arctic Bioscience

Arctic Bioscience – First patient included in HRO350 Phase IIb clinical trial in the UK 12 jan 2023 18:21

Arctic Bioscience

Arctic Bioscience – Clinical Trial Application for HRO350 Phase IIb approved in the UK 31 okt 2022 08:00

Arctic Bioscience

Arctic Bioscience - Q3 2022 Operational update – Positive progress in both pharma and nutra 10 okt 2022 07:57

Arctic Bioscience

Arctic Bioscience – Clinical Trial Application for HRO350 Phase IIb submitted 03 okt 2022 14:49

Arctic Bioscience

Arctic Bioscience – Clinical Trial Application for HRO350 Phase IIb - update 26 sep 2022 17:10

Arctic Bioscience

Arctic Bioscience – Webcast from Capital Markets Update available on web 21 sep 2022 08:00

Arctic Bioscience

Arctic Bioscience – Capital markets update 13 sep 2022 08:13

Arctic Bioscience

Arctic Bioscience - Invitation to capital markets update 25 aug 2022 08:00

Arctic Bioscience

Arctic Bioscience – Revenue growth and HRO350 Phase IIb clinical trial on track